- Report
- October 2025
- 150 Pages
Global
From €4305EUR$4,850USD£3,730GBP
- Report
- November 2025
- 160 Pages
Global
From €2981EUR$3,358USD£2,583GBP
€3507EUR$3,950USD£3,038GBP
- Report
- January 2026
- 86 Pages
Global
From €3500EUR$4,223USD£3,139GBP
- Report
- February 2026
- 90 Pages
Global
From €3500EUR$4,223USD£3,139GBP
- Training
- December 2026
- 2 Days
Global
€1552EUR$1,809USD£1,299GBP
€1791EUR$2,088USD£1,499GBP
- Training
- December 2026
- 2 Days
Global
€1552EUR$1,809USD£1,299GBP
€1791EUR$2,088USD£1,499GBP
- Training
- September 2026
- 2 Days
Global
€1552EUR$1,809USD£1,299GBP
€1791EUR$2,088USD£1,499GBP
- Training
- June 2026
- 2 Days
Global
€1791EUR$2,088USD£1,499GBP
- Training
- June 2026
- 2 Days
Global
€1791EUR$2,088USD£1,499GBP
- Training
- November 2025
- 2 Days
Global
From €1356EUR$1,528USD£1,175GBP
€1596EUR$1,798USD£1,383GBP
- Report
- November 2025
- 37 Pages
Asia Pacific
From €2885EUR$3,250USD£2,500GBP
- Report
- November 2025
- 58 Pages
Europe
From €2885EUR$3,250USD£2,500GBP
- Report
- May 2024
- 248 Pages
Global
From €4394EUR$4,950USD£3,807GBP
- Report
- October 2022
- 204 Pages
Global
From €4394EUR$4,950USD£3,807GBP
- Report
- July 2022
- 176 Pages
Global
From €4394EUR$4,950USD£3,807GBP
- Report
- August 2024
- 66 Pages
Global
From €1110EUR$1,250USD£961GBP
- Report
- May 2025
- 150 Pages
Global
From €5282EUR$5,950USD£4,577GBP
- Report
- August 2024
- 100 Pages
Global
From €5282EUR$5,950USD£4,577GBP
- Report
- October 2024
- 180 Pages
Global
From €3995EUR$4,500USD£3,461GBP
- Report
- February 2024
- 112 Pages
Global
From €4217EUR$4,750USD£3,654GBP

Quality by Design (QbD) is a systematic approach to pharmaceutical manufacturing that focuses on product and process understanding, design, and control. It is based on the principles of risk management and quality assurance, and is intended to ensure that products meet their intended quality, safety, and efficacy requirements. QbD is a holistic approach to product development that involves the integration of product and process design, development, and control. It is a proactive approach to product development that seeks to identify and address potential risks before they become problems.
QbD is becoming increasingly important in the pharmaceutical industry, as it helps to ensure that products are safe and effective. It also helps to reduce costs associated with product development and manufacturing, as well as improve product quality and consistency.
Some companies in the QbD market include Merck, Pfizer, Novartis, GlaxoSmithKline, AstraZeneca, and Sanofi. Show Less Read more